Industry recognition for Novagraaf’s Norwich experts
London, November 26, 2012 – Two senior professionals from the Norwich office of Intellectual Property (IP) consultancy Novagraaf have been recognised for their expertise in diverse IP fields. The work of European Trademark Attorney Susan Wall was recommended along with Novagraaf UK in the 2013 edition of the Legal500, while European and UK Patent Attorney Dr Oliver Harris has been elected as a Fellow of the Chartered Institute of Patent Attorneys (CIPA). Novagraaf is proud to be the only dedicated patent and trademark consultancy in Norfolk to be featured in the Legal500 (2013 edition), and the only provider in Norwich whose patent professionals are all Fellows of CIPA.
Susan Wall is a European Trademark Attorney with specific expertise in the strategic management of IP portfolios in a broad range of industries. She advises clients on all aspects of UK and foreign trademark work, both contentious and non-contentious, and acts for clients before the UK and European Community Trade Mark (CTM) IP offices registering and defending trademark rights.
Her work was recommended in the 2013 edition of the Legal500, along with Alastair Rawlence from Novagraaf UK’s Manchester office, and Novagraaf UK’s Trademark Practice as a whole. Commenting on her recommendation, Ms Wall says: “We work hard at Novagraaf Norwich to deliver to our clients a quality service that is as tailored to their specific needs as it is professional and effective. On a personal note, it is incredibly gratifying that our clients have recognised the quality of the advice that we provide, and the effort that we dedicate to ensuring that our work supports them and their business needs.”
Dr Oliver Harris is a dual-qualified UK and European Patent Attorney with extensive experience of drafting and prosecuting patent applications on both a national and overseas basis. He handles a range of subject matter for Novagraaf UK’s clients in the East of England, but specialises in the Life Sciences, particularly pharmaceuticals and biotechnology. He was elected as a Fellow of CIPA by other Fellows of the Institute in recognition of his qualifications, good repute and professional standing.
Commenting on his appointment, Dr Harris says: “Norfolk and the East of England is a vibrant business region and a real hub for innovation. The companies that operate here need strategic partners who share their vision and appetite for quality. That’s why the Norwich office has invested so much in its team, and their ongoing training and professional growth. We are constantly striving to be the best at what we do, so that our clients get the best results without needing to look outside the region for the appropriate level of knowledge, expertise and service.”
Tom Farrand, head of Novagraaf UK’s Trademark Practice, comments: “As IP protection becomes ever more important for companies seeking to build and enforce their businesses regionally, nationally and globally, it’s crucial for IP consultancy firms to be able to provide both global and tailored local support. The wider Novagraaf Group has the resources and the experience to support businesses wherever they operate with IP-specific solutions that provide insight and deliver value, while the regional offices of Novagraaf UK specialise in tailoring those solutions to their local clients via the expertise of professionals such as Susan, Alastair and Oliver. It is this local and bespoke approach that we believe makes a real difference to our clients in the UK.”
About Novagraaf Headquartered in the Netherlands, the Novagraaf Group has offices throughout Europe in IP hotspots such as Amsterdam, Brussels, Geneva and Paris. Its UK operation is based in London, Manchester and Norwich.
Novagraaf is among the top five service providers in the field of IP in Europe. Novagraaf currently employs over 350 dedicated professionals and staff members through its 13 offices and offers a wide range of advisory and management services in the IP field. For more information, visit our website: www.novagraaf.com.